SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-23-029869
Filing Date
2023-06-14
Accepted
2023-06-14 17:19:59
Documents
12
Period of Report
2023-05-19
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc20054447_8ka.htm   iXBRL 8-K/A 30345
  Complete submission text file 0001140361-23-029869.txt   175207

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20230519.xsd EX-101.SCH 3862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20230519_lab.xml EX-101.LAB 23988
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20230519_pre.xml EX-101.PRE 17038
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054447_8ka_htm.xml XML 4545
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38537 | Film No.: 231015096
SIC: 2836 Biological Products, (No Diagnostic Substances)